Trial Profile
A 15-Week, Double-Blind, Randomized, Active-Controlled, Multi-Center Study With 24-Week Extension to Evaluate the Safety, Tolerability, Efficacy of Alendronate 70 mg Plus Vitamin D3 2800 IU Combination Tablet in Men and Postmenopausal Women With Osteoporosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Alendronic acid/colecalciferol (Primary) ; Alendronic acid
- Indications Male osteoporosis; Osteoporosis; Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Organon
- 24 Apr 2009 New trial record